28107521|t|Differential Roles of AXIN1 and AXIN2 in Tankyrase Inhibitor-Induced Formation of Degradasomes and β-Catenin Degradation
28107521|a|Inhibition of the tankyrase enzymes (TNKS1 and TNKS2) has recently been shown to induce highly dynamic assemblies of β-catenin destruction complex components known as degradasomes, which promote degradation of β-catenin and reduced Wnt signaling activity in colorectal cancer cells. AXIN1 and AXIN2 / Conductin, the rate-limiting factors for the stability and function of endogenous destruction complexes, are stabilized upon TNKS inhibition due to abrogated degradation of AXIN by the proteasome. Since the role of AXIN1 versus AXIN2 as scaffolding proteins in the Wnt signaling pathway still remains incompletely understood, we sought to elucidate their relative contribution in the formation of degradasomes, as these protein assemblies most likely represent the morphological and functional correlates of endogenous β-catenin destruction complexes. In SW480 colorectal cancer cells treated with the tankyrase inhibitor (TNKSi) G007-LK we found that AXIN1 was not required for degradasome formation. In contrast, the formation of degradasomes as well as their capacity to degrade β-catenin were considerably impaired in G007-LK-treated cells depleted of AXIN2. These findings give novel insights into differential functional roles of AXIN1 versus AXIN2 in the β-catenin destruction complex.
28107521	0	12	Differential	T080	C1705242
28107521	13	18	Roles	T078	C1552020
28107521	22	27	AXIN1	T116,T123	C1438871
28107521	32	37	AXIN2	T116,T123	C1454580
28107521	41	50	Tankyrase	T116,T126	C0963182
28107521	51	68	Inhibitor-Induced	T121	C0014432
28107521	69	78	Formation	T169	C1522492
28107521	82	94	Degradasomes	T116,T123	C1180347
28107521	99	108	β-Catenin	T116,T123	C0105770
28107521	109	120	Degradation	T169	C0243125
28107521	121	131	Inhibition	T039	C1524081
28107521	139	156	tankyrase enzymes	T116,T126	C0963182
28107521	158	163	TNKS1	T116,T126	C1504783
28107521	168	173	TNKS2	T116,T126	C1448153
28107521	209	215	highly	T080	C0205250
28107521	216	223	dynamic	T169	C0729333
28107521	224	234	assemblies	T044	C0872376
28107521	238	247	β-catenin	T116,T123	C0105770
28107521	248	267	destruction complex	T104	C1704241
28107521	268	278	components	T116,T123	C1179435
28107521	288	300	degradasomes	T116,T123	C1180347
28107521	308	315	promote	T052	C0033414
28107521	316	327	degradation	T169	C0243125
28107521	331	340	β-catenin	T116,T123	C0105770
28107521	345	352	reduced	T080	C0392756
28107521	353	366	Wnt signaling	T044	C1520113
28107521	367	375	activity	T169	C0205177
28107521	379	396	colorectal cancer	T191	C1527249
28107521	397	402	cells	T025	C0007634
28107521	404	409	AXIN1	T116,T123	C1438871
28107521	414	419	AXIN2	T116,T123	C1454580
28107521	422	431	Conductin	T116,T123	C1454580
28107521	437	450	rate-limiting	T169	C0489879
28107521	451	458	factors	T169	C1521761
28107521	467	476	stability	T080	C0205360
28107521	481	489	function	T169	C0542341
28107521	493	503	endogenous	T169	C0205227
28107521	504	525	destruction complexes	T104	C1704241
28107521	531	541	stabilized	T033	C0184512
28107521	547	551	TNKS	T116,T126	C0963182
28107521	552	562	inhibition	T039	C1524081
28107521	580	591	degradation	T169	C0243125
28107521	595	599	AXIN	T116,T123	C3178961
28107521	607	617	proteasome	T116,T123	C1180347
28107521	629	633	role	T078	C1552020
28107521	637	642	AXIN1	T116,T123	C1438871
28107521	650	655	AXIN2	T116,T123	C1454580
28107521	659	679	scaffolding proteins	T116,T123	C0033684
28107521	687	708	Wnt signaling pathway	T044	C1520113
28107521	715	722	remains	T080	C1527428
28107521	723	735	incompletely	T080	C0205257
28107521	736	746	understood	T041	C0162340
28107521	777	785	relative	T080	C0205345
28107521	786	798	contribution	T052	C1880177
28107521	806	815	formation	T169	C1522492
28107521	819	831	degradasomes	T116,T123	C1180347
28107521	842	849	protein	T116,T123	C0033684
28107521	850	860	assemblies	T044	C0872376
28107521	887	900	morphological	T082	C0543482
28107521	905	915	functional	T169	C0205245
28107521	916	926	correlates	T080	C1707520
28107521	930	940	endogenous	T169	C0205227
28107521	941	950	β-catenin	T116,T123	C0105770
28107521	951	972	destruction complexes	T104	C1704241
28107521	977	982	SW480	T025	C0007634
28107521	983	1000	colorectal cancer	T191	C1527249
28107521	1001	1006	cells	T025	C0007634
28107521	1007	1014	treated	T169	C1522326
28107521	1024	1043	tankyrase inhibitor	T121	C0014432
28107521	1045	1050	TNKSi	T121	C0014432
28107521	1052	1059	G007-LK	T109,T121	C3658785
28107521	1063	1068	found	T033	C0150312
28107521	1074	1079	AXIN1	T116,T123	C1438871
28107521	1101	1112	degradasome	T116,T123	C1180347
28107521	1113	1122	formation	T169	C1522492
28107521	1141	1150	formation	T169	C1522492
28107521	1154	1166	degradasomes	T116,T123	C1180347
28107521	1184	1192	capacity	T081	C1516240
28107521	1196	1203	degrade	T169	C0243125
28107521	1204	1213	β-catenin	T116,T123	C0105770
28107521	1219	1231	considerably	T078	C0750591
28107521	1232	1240	impaired	T169	C0221099
28107521	1244	1259	G007-LK-treated	T109,T121	C3658785
28107521	1260	1265	cells	T025	C0007634
28107521	1278	1283	AXIN2	T116,T123	C1454580
28107521	1291	1299	findings	T033	C0243095
28107521	1305	1310	novel	T080	C0205314
28107521	1311	1319	insights	T041	C0233820
28107521	1325	1337	differential	T080	C1705242
28107521	1338	1354	functional roles	T077	C1705810
28107521	1358	1363	AXIN1	T116,T123	C1438871
28107521	1371	1376	AXIN2	T116,T123	C1454580
28107521	1384	1393	β-catenin	T116,T123	C0105770
28107521	1394	1413	destruction complex	T104	C1704241